Hope vs. caution: ethical and regulatory considerations for neonatal stem cell therapies

The authors comment on the ethical and regulatory considerations for neonatal stem cell therapies.

Saved in:
Bibliographic Details
Published in:Pediatric research 2018-03, Vol.83 (3), p.557-558
Main Authors: Laventhal, Naomi T, Rivkees, Scott A, Opipari, Valerie P
Format: Article
Language:English
Subjects:
631/61/51/1844/2319
692/700/1720/3186
706/648/179
Brain Injuries - therapy
Chronic Disease
Clinical Trials as Topic - ethics
commentary
Congenital Abnormalities - therapy
Ethics, Medical
Federal regulation
Heart Diseases - congenital
Heart Diseases - therapy
Humans
Infant, Newborn
Medical ethics
Medical research
Medical treatment
Medicine
Medicine & Public Health
Newborn babies
Pediatric Surgery
Pediatrics
Pediatrics - methods
Stem Cell Transplantation - ethics
Stem Cell Transplantation - legislation & jurisprudence
Stem Cell Transplantation - methods
Stem cells
Vulnerable Populations
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The authors comment on the ethical and regulatory considerations for neonatal stem cell therapies.
ISSN:0031-3998
1530-0447
DOI:10.1038/pr.2017.320